CAP-accredited, CLIA-certified molecular diagnostics laboratory offering comprehensive proteomic and genomic characterization of patient tumor biopsies to guide cancer treatment decisions. Proprietary multiplexed method solubilizes proteins from FFPE tissue for mass‑spectrometry quantitation, with next‑generation sequencing from the same sample for targeted proteomic and genomic results.